MFN News

Language

Category

Year

26 Jan, 2023 Boule Diagnostics – Invitation to presentation of the year-end report 2022 News English IR

Boule Diagnostics AB will publish the year-end report for the period January – December 2022 at 07:30 CET, Thursday, February 2nd, 2023. Following the...

30 Dec, 2022 Change in number of shares and votes in Boule Diagnostics News English Regulatory LHFI IR

Stockholm, Sweden, December 30, 2022 – Boule Diagnostics AB (publ) (“Boule” or the “Company”) (Nasdaq Stockholm: BOUL) has, as previously announced...

14 Dec, 2022 Boule Diagnostics appoints Jan Benjaminson as interim CFO News English IR

Boule Diagnostics AB has today appointed Jan Benjaminson as interim CFO, effective on February 3rd, 2023. Jan will succeed Annette Colin who will continue...

30 Nov, 2022 Boule Diagnostics raises approximately SEK 150 million through a significantly oversubscribed rights issue News English Regulatory MAR IR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG...

28 Nov, 2022 Boule receives CE mark according to IVDR Class B for two product lines News English IR

Boule Medical AB has reached another important milestone in its preventive and diligent work in meeting the new and increased regulatory requirements for...

14 Nov, 2022 Trading of subscription rights commences Tuesday 15 November News English IR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG...

10 Nov, 2022 Boule Diagnostics publishes prospectus in connection with its Rights Issue News English IR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG...

10 Nov, 2022 Boule Diagnostics (publ) Interim report January–September 2022 News English Regulatory MAR Report Interim Q3 IR

A challenging third quarter Quarter July-September 2022 CEO Jesper Söderqvist Sales increased by 12 percent to SEK 126 million. Adjusted for exchange...

07 Nov, 2022 Boule Diagnostics – Invitation to presentation of the interim report Q3 2022 News English IR

Boule Diagnostics AB will publish the interim report for the period January – September 2022 at 07:30 CET, Thursday, November 10th, 2022. Following the...

01 Nov, 2022 Bulletin from the extraordinary general meeting in Boule Diagnostics on November 1, 2022 News English IR

Boule Diagnostics AB (”Boule”) held an extraordinary general meeting today November 1, 2022 (”EGM”). The complete proposals regarding the resolutions...

28 Oct, 2022 Boule Diagnostics – Nomination Committee for the 2023 Annual General Meeting News English IR

The Annual General Meeting, (”AGM”), 2022 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership...

20 Oct, 2022 Boule sets up contract manufacturing of reagents in India News English IR

Boule Diagnostics has signed a strategic contract manufacturing agreement with Q-Line Biotech for local hematology reagent manufacturing in India. India...

Previous Next

Medica 2023 Kvartalsrapport Q1, 2025